Materials you may find helpful in your exploration of the use of JYSELECA in the treatment of adult patients with moderately to severely active ulcerative colitis.

ECCO’22: what’s new for JYSELECA?

Dr Alissa Walsh from Oxford University Hospitals and Dr Daniel Gaya from the University of Glasgow Medical School examine JYSELECA data presented at ECCO 2022 and consider the implications for its use in clinical practice.